Physical activity and lung function-Cause or consequence?


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 09 09 2019
accepted: 03 08 2020
entrez: 21 8 2020
pubmed: 21 8 2020
medline: 21 10 2020
Statut: epublish

Résumé

Concerns exist that the positive association of physical activity with better lung function, which has been suggested in previous longitudinal studies in smokers, is due to reverse causation. To investigate this, we applied structural equation modeling (SEM), an exploratory approach, and marginal structural modeling (MSM), an approach from the causal inference framework that corrects for reverse causation and time-dependent confounding and estimates causal effects, on data from participants in the European Community Respiratory Health Survey (ECRHS, a multicentre European cohort study initiated in 1991-1993 with ECRHS I, and with two follow-ups: ECRHS II in 1999-2003, and ECRHS III in 2010-2014). 753 subjects who reported current smoking at ECRHS II, with repeated data on lung function at ECRHS I, II and III, physical activity at ECRHS II and III, and potential confounders at ECRHS I and II, were included in the analyses. SEM showed positive associations between physical activity and lung function in both directions. MSM suggested a protective causal effect of physical activity on lung function (overall difference in mean β (95% CI), comparing active versus non-active individuals: 58 mL (21-95) for forced expiratory volume in one second and 83 mL (36-130) for forced vital capacity). Our results suggest bi-directional causation and support a true protective effect of physical activity on lung function in smokers, after accounting for reverse causation and time-dependent confounding.

Identifiants

pubmed: 32817718
doi: 10.1371/journal.pone.0237769
pii: PONE-D-19-25355
pmc: PMC7446897
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0237769

Subventions

Organisme : Medical Research Council
ID : MR/S019669/1
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Epidemiol Community Health. 2004 Apr;58(4):265-71
pubmed: 15026432
BMC Public Health. 2020 Jan 6;20(1):6
pubmed: 31906909
Am J Epidemiol. 2002 Jul 15;156(2):139-47
pubmed: 12117705
Eur Respir J. 1994 May;7(5):954-60
pubmed: 8050554
Tuberc Respir Dis (Seoul). 2019 Oct;82(4):311-318
pubmed: 31172706
Ann Epidemiol. 2008 Oct;18(10):775-83
pubmed: 18708291
ERJ Open Res. 2018 Aug 03;4(3):
pubmed: 30083551
Respirology. 2017 Feb;22(2):278-283
pubmed: 27696634
Eur Respir J. 2002 Nov;20(5):1071-9
pubmed: 12449157
J Nutr. 2012 Jun;142(6):1009-18
pubmed: 22513989
Lancet. 2012 Jul 21;380(9838):258-71
pubmed: 22818938
Thorax. 2018 Apr;73(4):376-384
pubmed: 29306902
Clin Sci (Lond). 2010 Feb 09;118(9):565-72
pubmed: 20132099
Am J Respir Crit Care Med. 2007 Mar 1;175(5):458-63
pubmed: 17158282
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
Am J Epidemiol. 2012 Oct 1;176(7):608-12
pubmed: 22956513
BMC Pulm Med. 2017 Dec 28;17(1):215
pubmed: 29282101
BMC Med. 2020 May 13;18(1):134
pubmed: 32398155
Am J Respir Crit Care Med. 2003 Aug 15;168(4):494-9
pubmed: 12791579
Br J Sports Med. 2003 Dec;37(6):521-8
pubmed: 14665592
Epidemiology. 2000 Sep;11(5):550-60
pubmed: 10955408

Auteurs

Annabelle Bédard (A)

ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiologia y Salud Pública (CIBERESP), Barcelona, Spain.

Anne-Elie Carsin (AE)

ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiologia y Salud Pública (CIBERESP), Barcelona, Spain.

Elaine Fuertes (E)

ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiologia y Salud Pública (CIBERESP), Barcelona, Spain.
National Heart and Lung Institute, Imperial College London, London, United Kingdom.

Simone Accordini (S)

Unit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.

Shyamali C Dharmage (SC)

Allergy and Lung Health Unit, School of Population and Global Health, University of Melbourne, Melbourne, Australia.

Vanessa Garcia-Larsen (V)

Program in Human Nutrition, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.

Joachim Heinrich (J)

Allergy and Lung Health Unit, School of Population and Global Health, University of Melbourne, Melbourne, Australia.
Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital Munich, Ludwig Maximilians University Munich, Munich, Germany.

Christer Janson (C)

Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.

Ane Johannessen (A)

Centre for International Health, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Department of Occupational Medicine, Haukeland University Hospital, Bergen, Norway.

Bénédicte Leynaert (B)

Inserm, UMR 1152, Pathophysiology and Epidemiology of Respiratory Diseases, Paris, France.
UMR 1152, University Paris Diderot, Paris, France.

José Luis Sánchez-Ramos (JL)

Pneumology Service, Juan Ramón Jiménez Hospital, Huelva, Spain.

Gabriela P Peralta (GP)

ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiologia y Salud Pública (CIBERESP), Barcelona, Spain.

Isabelle Pin (I)

CHU Grenoble Alpes, Department of Pediatrics, Grenoble, France.
INSERM, Institut for Advanced Biosciences, Grenoble, France.
University Grenoble Alpes, Grenoble, France.

Giulia Squillacioti (G)

Department of Public Health and Pediatrics, University of Turin, Turin, Italy.

Joost Weyler (J)

Department of Epidemiology and Social Medicine, University of Antwerp, Antwerp, Belgium.

Deborah Jarvis (D)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.
MRC-PHE Centre for Environment and Health, Imperial College London, London, United Kingdom.

Judith Garcia-Aymerich (J)

ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiologia y Salud Pública (CIBERESP), Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH